Effects of rivaroxaban on coagulation tests in patients with non-valvular atrial fibrillation under real-life conditions

Novel oral anticoagulants (NOACs), such as direct factor Xa inhibitors, are effective alternatives for anticoagulation therapy in stroke prevention in atrial fibrillation patients.

Source: Thrombosis Research - March 7, 2017 Category: Hematology Authors: V.M. Silva, M. Scanavacca, F. Darrieux, C. Cavalheiro-Filho, C.C. Strunz Tags: Letter to the Editors-in-Chief Source Type: research